Court certifies $891M class-action Community Health Systems lawsuit

Wooden gavel and gold legal scale that appear to have sunlight falling on them
An $891 million class-action lawsuit was filed against the Franklin, Tennessee-based health system in the U.S. District Court for the Middle District of Tennessee in May, court filings show. (Getty Images/William_Potter)

Hospital giant Community Health Systems is facing an $891 million class-action lawsuit after a District Court certified the case.

The federal securities class action suit was filed against the Franklin, Tennessee-based health system in the U.S. District Court for the Middle District of Tennessee in May, court filings show.

It sought class certification on behalf of purchasers of our common stock between Feb. 20, 2017, and Feb. 27, 2018, and alleges misleading statements resulted in artificially inflated prices for our common stock. The certification was granted late last month.

Free Daily Newsletter

Like this story? Subscribe to FierceHealthcare!

The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.

The case stems back to 2011 when the health system was attempting to acquire Dallas-based Tenet Healthcare, the Nashville Business Journal reported

RELATED: Community Health Systems-owned hospital chain agrees to pay $262M settlement for kickback, fraud allegations

The case consolidated three class-action cases seeking class certification on behalf of purchasers of our common stock between July 27, 2006, and April 11, 2011. They alleged misleading statements resulted in artificially inflated prices for CHS' common stock. 

Specifically, those claims in the securities fraud lawsuit came from Tenet officials who alleged multiple counts of fraud through failing to disclose “improper” admissions practices they said artificially inflated CHS' stock price, the Nashville post reported.  

The company denies the claims.

"We believe this matter is without merit and will vigorously defend this case," CHS officials said in a recent Securities and Exchange Commission filing

Suggested Articles

A KHN investigation found that manufacturers, hospitals, doctors and some patient advocates have put marketing muscle behind 3D mammograms.

CVS Health is joining forces with UPS to test several different applications for drone delivery, including sending products directly to patients.

A federal judge won't give the Trump administration more time to repay hospitals affected by $380 million in site-neutral payment cuts.